Shares of Aurora Cannabis Inc. (ACB) jumped over 50% on Wednesday morning after the medical cannabis company reported its third-quarter results.
ACB is currently trading at $5.58, up $1.90 or 51.51%, on the Nasdaq. The stock opened its trading at $4.67 after closing Tuesday at $3.68. The stock has traded between $2.84 and $9.35 in the past 52-week period.
The company reported net income from continuing operations of $31.2 million compared to a net loss of $17.1 million for the prior year period. The increase in net income of $48.3 million primarily relates to the improvement in gross profit of $54.0 million, partially offset by a decrease in other income of $5.3 million.
Net revenue for the quarter was $88.2 million, as compared to $64.4 million in the prior year period. The 37% increase from the prior period was mainly due to 51% growth in our global medical cannabis business and 22% growth in our plant propagation business, slightly offset by lower quarterly revenue in our consumer cannabis business.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.